Europe Genomics Market

The genomic market in Europe is growing at a steady pace from the past decade and is expected to grow at a CAGR of 10.60% to reach USD 10.10 Billion by 2025. Genomics focuses on the structure and functionalities of the genomes. Genomes give information about the individual genes and their roles in inheritance. This technology in the DNA sequencing made complex systems research easy and also appropriate.

Market Dynamics:

• An increasing number of research institutes in the study of DNA sequencing and analyzing various procedures to intensify the diagnostic process is the key driving factor for the market to grow. In addition to this rise in the investments in the biological studies is accelerating the demand of the market.  Growing capital income in most of the countries is also greatly influencing the demand of the market. Also, the market is magnified by increasing study on the genomics projects.
• However, increasing risks in real-time applications is to impede the demand of the market. Also, the lack of sufficient knowledge in monitoring the reports due to a lack of training programs remains as a challenging factor for the market. Cost for installation and maintenance of the devices especially in laboratories is degrading the demand of the market.
• Acceptance of newly developed instruments in the laboratories and introducing innovative procedures for the medical sector promote quality treatment is solely to surge growth opportunities for the market. Rising support from the government by changing schemes in favor to the common people are elevating the demand of the market.

Consumables segment is accounted to lead with the highest shares of the market

Based on the product and service, the market is bifurcated into Consumables, systems & software and services. Consumables segment is leading with the highest shares of the market. The rise in the scale of hospitals and clinics across the regions are mainly propelling the demand of the market.

Diagnostic applications are to hit the highest growth rate in the review period

By application, the market is segmented into Diagnostics and precision medicine. Diagnostics applications are leading with the highest shares of the market and also to strike the highest CAGR by 2022. Increasing diabetic patients along with growing geriatric population are mainly boosting up the demand of the market. Increasing startup companies with new applications are likely to bolster the demand of the market. Also, the market is fueled by the growing demand for better treatment procedures, especially for chronic diseases.

Research centers and academic & government initiatives are witnessed to have growth opportunities in the coming years

On the basis of end-user, the market is divided into research centers and academic & government initiatives, hospitals and clinics. Research centers and academic & government initiatives sector is holding the highest shares of the market. The growing number of projects and also increasing demand to evaluate new applications are broadening the growth of the market.

Germany to lead the Europe Genomics Market

Geographically, the global market is led by Europe by owing to the acceptance of the latest technological advancements in the research centers. Growing prevalence of effective treatment procedures is sure to escalate the demand of the market. Increasing applications over genomes and increasing scale of healthcare centers along with diagnostic applications are ascribed to outshine the demand of the market.  Also, increasing focus on to develop new techniques to handle complex applications in a simple way is mainly propelling the demand of the market in this region. Growing prevalence for the decrease in the sequencing costs is merely to boost up the demand of the market.

Some of the prominent players in the Europe genomic market are Thermo Fisher Scientific Inc., Illumina Inc., Eurofins, Qiagen, Agilent Technologies, BGI, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Danaher and GE Healthcare.

Few of the leading companies dominating the Market profiled in the report are

• Qiagen
• Illumina, Inc.
• Ge Healthcare
• Eppendorf
• Agilent Technologies
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Danaher Corporation
• F. Hoffmann-La Roche
• Eurofins Scientific
• BGI
• Oxford Nanopore Technologies

This research report includes following segmentation for the Europe Genomics Market size and forecast until 2025

Europe Genomics Market Analysis - By Product

• Services
• Systems and Software
• Consumables

Europe Genomics Market Analysis - By Technology

• Micro Array
• Sequencing
• Nucleic Acid Extraction and Purification
• Other

Europe Genomics Market Analysis - By Application

• Drug Discovery and Development
• Agriculture and Animal Research
• Diagnostics

Europe Genomics Market Analysis - By End User:

• Hospitals and Clinics
• Research Centers
• Academic & Government Institutes
• Pharmaceutical and Biotechnology Companies
• Other End Users

Europe Genomics Market Analysis - By Region

• United Kingdom
• Germany
• France
• Italy
• Spain